Neurological complications of brucella spondylitis

• Published in: Acta neurologica Scandinavica Vol. 81; no. 1; p. 16
• Main Authors: Mousa, A M, Bahar, R H, Araj, G F, Koshy, T S, Muhtaseb, S A, al-Mudallal, D S, Marafie, A A
• Format: Journal Article
• Language: English
• Published: Denmark 01-01-1990
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Brucellosis - complications; Brucellosis - drug therapy; Female; Humans; Lumbar Vertebrae - diagnostic imaging; Male; Middle Aged; Nervous System Diseases - microbiology; Nervous System Diseases - physiopathology; Spondylitis - complications; Spondylitis - diagnostic imaging; Spondylitis - microbiology; Streptomycin - therapeutic use; Tomography, X-Ray Computed
• ISSN: 0001-6314
• DOI: 10.1111/j.1600-0404.1990.tb00925.x

Twenty-two patients with brucella spondylitis and neurobrucellosis were studied during a 2-year period. The diagnosis was based on history of exposure, compatible signs and symptoms, high antibody titre and/or positive culture of a clinical specimen(s). Spondylitis was confirmed by plain radiographs, bone scan, CT and in some cases by histology. Neurobrucellosis was confirmed by CSF examination and culture, myelography, NCV, EMG and CT head. The spondylitis was early in 4 cases, chronic active in 12, smouldering "partially healed" in 3 and healed in 3 cases. Of these, 15 patients (68%) had neurological complications of various types. Plain radiographs were not a good index of activity of spondylitis. Tc99 bone scan was not specific and it remained positive long after the completion of therapy. CT was superior in revealing details of bone destruction, soft tissue swelling and entrapment of nerve roots and cord. The 3 modalities were complementary. Spondylitis is commonly associated with neurobrucellosis and symptoms of one may over shadow those of the other and in some cases neurobrucellosis may be subclinical. In all cases of spondylitis, a thorough search for neurobrucellosis should be made and vice versa. Prolonged treatment with a combination of 3 anti-brucella drugs is recommended and prolonged follow-up is necessary.